Alcon Research, LLC /
STAAR Surgical Company
Alcon Research and STAAR Surgical amend merger terms
Source for the buyer and target: STAAR Surgical Company
For the buyer and target.
“On December 9, 2025, STAAR Surgical Company (the “Company”) entered into Amendment No. 2 (the “Amendment”) to the Agreement and Plan of Merger, dated August 4, 2025 (as amended, the “Amended Merger Agreement”), with Alcon Research, LLC (“Alcon”) and Rascasse Merger Sub, Inc. (“Merger Sub”).”
Published 9 Dec 2025
Open the sourceWhat happened
Alcon Research, LLC and STAAR Surgical Company amended their merger agreement, increasing the proposed cash consideration to $30.75 per share of Company common stock. [01]
The merger remains subject to consummation. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Alcon Research and STAAR Surgical amend merger terms
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly